The PROTECT study: final results of a large multicenter postmarketing study in patients with type 2 diabetes
- 30 April 1998
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 20 (2) , 257-269
- https://doi.org/10.1016/s0149-2918(98)80089-1
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- PROTECT interim results: a large multicenter study of patients with type II diabetesClinical Therapeutics, 1997
- Reduction of Glycosylated Hemoglobin and Postprandial Hyperglycemia by Acarbose in Patients With NIDDM: A placebo-controlled dose-comparison studyDiabetes Care, 1995
- Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitusThe American Journal of Medicine, 1995
- Long-term efficacy and safety of acarbose in the treatment of obese subjects with non-insulin-dependent diabetes mellitusArchives of internal medicine (1960), 1994
- AcarboseDrugs, 1988